Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC10610 Adapalene RARβ and RARγ agonist Adapalene  Chemical Structure
  3. GC46798 Adapalene-d3 An internal standard for the quantification of adapalene Adapalene-d3  Chemical Structure
  4. GC13959 Adarotene An atypical retinoid Adarotene  Chemical Structure
  5. GC65880 ADH-6 TFA ADH-6 TFA is a tripyridylamide compound. ADH-6 abrogates self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD. ADH-6 TFA targets and dissociates mutant p53 aggregates in human cancer cells, which restores p53's transcriptional activity, leading to cell cycle arrest and apoptosis. ADH-6 TFA has the potential for the research of cancer diseases. ADH-6 TFA  Chemical Structure
  6. GC42735 Adipostatin A Adipostatin A (Adipostatin A) is a glycerol-3-phosphate dehydrogenase (GPDH) inhibitor with an IC50 of 4.1 μM. Adipostatin A  Chemical Structure
  7. GC11892 AEE788 (NVP-AEE788) AEE788 (NVP-AEE788) is an inhibitor of the EGFR and ErbB2 with IC50 values of 2 and 6 nM, respectively. AEE788 (NVP-AEE788)  Chemical Structure
  8. GC42743 AEM1 Cancer cell survival appears partly dependent on antioxidative enzymes, whose expression is regulated by the Keap1-Nrf2 pathway, to quench potentially toxic reactive oxygen species generated by their metastatic transformation. AEM1  Chemical Structure
  9. GC13168 AG 825 Selective ErbB2 inhibitor AG 825  Chemical Structure
  10. GC13697 AG-1024 Selective IGF-1R inhibitor AG-1024  Chemical Structure
  11. GC17881 AGK 2

    AGK2 is a selective SIRT2 inhibitor, with an IC50 of 3.

    AGK 2  Chemical Structure
  12. GC39584 AGN194204 AGN194204 (IRX4204) is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. AGN194204  Chemical Structure
  13. GC16120 AI-3 Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor AI-3  Chemical Structure
  14. GC46821 Ajoene A disulfide with diverse biological activities Ajoene  Chemical Structure
  15. GC39620 AKOS-22 AKOS-22  Chemical Structure
  16. GC11589 AKT inhibitor VIII A potent inhibitor of Akt1 and Akt2 AKT inhibitor VIII  Chemical Structure
  17. GC35275 AKT-IN-3 AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1, Akt2 and Akt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 (compound E22) induces apoptosis and inhibits metastasis of cancer cells. AKT-IN-3  Chemical Structure
  18. GC49773 Albendazole sulfone-d3 An internal standard for the quantification of albendazole sulfone Albendazole sulfone-d3  Chemical Structure
  19. GC48848 Albendazole-d7 An internal standard for the quantification of albendazole Albendazole-d7  Chemical Structure
  20. GC41080 Albofungin Albofungin is a xanthone isolated from A. Albofungin  Chemical Structure
  21. GC16597 Alda 1

    ALDH2 activator

    Alda 1  Chemical Structure
  22. GC35288 Alkannin A naphthoquinone with diverse biological activities Alkannin  Chemical Structure
  23. GC49393 all-trans-13,14-Dihydroretinol A metabolite of all-trans retinoic acid all-trans-13,14-Dihydroretinol  Chemical Structure
  24. GC32127 Alofanib (RPT835) Alofanib (RPT835) (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2). Alofanib (RPT835)  Chemical Structure
  25. GC14314 Aloperine An alkaloid Aloperine  Chemical Structure
  26. GC35306 alpha-Mangostin alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM. alpha-Mangostin  Chemical Structure
  27. GC18437 Alternariol monomethyl ether Alternariol monomethyl ether, isolated from the roots of Anthocleista djalonensis (Loganiaceae), is an important taxonomic marker of the plant species. Alternariol monomethyl ether  Chemical Structure
  28. GC33356 AM-8735 AM-8735 is a potent and selective MDM2 inhibitor with an IC50 of 25 nM. AM-8735  Chemical Structure
  29. GC42776 Amarogentin

    A secoiridoid glycoside with diverse biological activities

    Amarogentin  Chemical Structure
  30. GN10484 Amentoflavone Amentoflavone  Chemical Structure
  31. GC42783 Ametantrone Ametantrone (NSC 196473) is an antitumor agent that intercalates into DNA and induces topoisomerase II (TOP2)-mediated DNA break. Ametantrone  Chemical Structure
  32. GC19452 AMG-176 AMG-176 (AMG-176) is a potent, selective and orally active MCL-1 inhibitor, with a Ki of 0.13 nM. AMG-176  Chemical Structure
  33. GC15828 AMG232 AMG232 (AMG 232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction, with an IC50 of 0.6 nM. AMG232 binds to MDM2 with a Kd of 0.045 nM. AMG232  Chemical Structure
  34. GC42785 Amifostine (hydrate) Amifostine (hydrate) (WR2721 trihydrate) is a broad-spectrum cytoprotective agent and a radioprotector. Amifostine (hydrate) selectively protects normal tissues from damage caused by radiation and chemotherapy. Amifostine (hydrate) is potent hypoxia-inducible factor-α1 (HIF-α1) and p53 inducer. Amifostine (hydrate) protects cells from damage by scavenging oxygen-derived free radicals. Amifostine (hydrate) reduces renal toxicity and has antiangiogenic action. Amifostine (hydrate)  Chemical Structure
  35. GC61804 Amifostine thiol Amifostine thiol (WR-1065) is an active metabolite of the cytoprotector Amifostine. Amifostine thiol is a cytoprotective agent with radioprotective abilities. Amifostine thiol activates p53 through a JNK-dependent signaling pathway. Amifostine thiol  Chemical Structure
  36. GC12051 Amiloride HCl dihydrate Amiloride HCl dihydrate (MK-870 hydrochloride dihydrate) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]). Amiloride HCl dihydrate  Chemical Structure
  37. GC63932 Amsilarotene Amsilarotene (TAC-101; Am 555S), an orally active synthetic retinoid, has selective affinity for retinoic acid receptor α (RAR-α) binding with Ki of 2.4, 400 nM for RAR-α and RAR-β. Amsilarotene induces the apoptotic of human gastric cancer, hepatocellular carcinoma and ovarian carcinoma cells. Amsilarotene can be used for the research of cancer. Amsilarotene  Chemical Structure
  38. GC16391 Amuvatinib (MP-470, HPK 56) A multi-targeted RTK inhibitor Amuvatinib (MP-470, HPK 56)  Chemical Structure
  39. GC48339 Amycolatopsin A A macrolide polyketide with antimycobacterial and anticancer activities Amycolatopsin A  Chemical Structure
  40. GC48341 Amycolatopsin B A bacterial metabolite Amycolatopsin B  Chemical Structure
  41. GC48350 Amycolatopsin C A polyketide macrolide with antimycobacterial and anticancer activities Amycolatopsin C  Chemical Structure
  42. GC42806 Andrastin A Andrastin A is a meroterpenoid farnesyltransferase inhibitor. Andrastin A  Chemical Structure
  43. GN10045 Angelicin Angelicin  Chemical Structure
  44. GC60584 Angiotensin II human acetate

    Angiotensin II human (Angiotensin II) acetate is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system.

    Angiotensin II human acetate  Chemical Structure
  45. GC42813 Anguinomycin A Anguinomycin A is an antibiotic first isolated from a Streptomyces sp. Anguinomycin A  Chemical Structure
  46. GC40614 Anhydroepiophiobolin A Anhydroepiophiobolin A, an analog of Ophiobolin A, is a potent inhibitor of photosynthesis (I50s of 6.1 and 1 mM for photosynthesis in Chlorella and Spinach, respectively). Anhydroepiophiobolin A  Chemical Structure
  47. GC40214 Anhydroophiobolin A Anhydroophiobolin A is an ophiobolin fungal metabolite that has been found in C. Anhydroophiobolin A  Chemical Structure
  48. GC11559 Anisomycin

    JNK agonist, potent and specific

    Anisomycin  Chemical Structure
  49. GC49259 Antagonist G (trifluoroacetate salt) A neuropeptide antagonist Antagonist G (trifluoroacetate salt)  Chemical Structure
  50. GC66337 Anti-Mouse PD-L1 Antibody Anti-Mouse PD-L1 Antibody is an anti-mouse PD-L1 IgG2b antibody inhibitor derived from host Rat. Anti-Mouse PD-L1 Antibody  Chemical Structure
  51. GC35361 Antineoplaston A10 Antineoplaston A10, a naturally occurring substance in human body, is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer. Antineoplaston A10  Chemical Structure
  52. GC34172 AP1867 AP1867 is a synthetic FKBP12F36V-directed ligand. AP1867  Chemical Structure
  53. GC61745 AP1867-2-(carboxymethoxy) AP1867-2-(carboxymethoxy), the AP1867 (a synthetic FKBP12F36V-directed ligand) based moiety, binds to CRBN ligand via a linker to form dTAG molecules. AP1867-2-(carboxymethoxy)  Chemical Structure
  54. GC15586 AP1903 AP1903 (AP1903) is a dimerizer agent that acts by cross-linking the FKBP domains. AP1903 (AP1903) dimerizes the Caspase 9 suicide switch and rapidly induces apoptosis. AP1903  Chemical Structure
  55. GC14498 AP20187 Dimerizer,synthetic and cell-permeable AP20187  Chemical Structure
  56. GC18518 Apcin Apcin is an inhibitor of the E3 ligase activity of the mitotic anaphase-promoting complex/cyclosome (APC/C). Apcin  Chemical Structure
  57. GC62419 Apcin-A Apcin-A, an Apcin derivative, is an anaphase-promoting complex (APC) inhibitor. Apcin-A interacts strongly with Cdc20, and inhibits the ubiquitination of Cdc20 substrates. Apcin-A can be used to synthesize the PROTAC CP5V. Apcin-A  Chemical Structure
  58. GC35367 APG-115 APG-115 (APG-115) is an orally active MDM2 protein inhibitor binding to MDM2 protein with IC50 and Ki values of 3.8 nM and 1 nM, respectively. APG-115 blocks the interaction of MDM2 and p53 and induces cell-cycle arrest and apoptosis in a p53-dependent manner. APG-115  Chemical Structure
  59. GC62640 APG-1387 APG-1387, a bivalent SMAC mimetic and an IAP antagonist, blocks the activity of IAPs family proteins (XIAP, cIAP-1, cIAP-2, and ML-IAP). APG-1387 induces degradation of cIAP-1 and XIAP proteins, as well as caspase-3 activation and PARP cleavage, which leads to apoptosis. APG-1387 can be used for the research of hepatocellular carcinoma, ovarian cancer, and nasopharyngeal carcinoma. APG-1387  Chemical Structure
  60. GC12961 Apicidin

    A cell-permeable HDAC inhibitor

    Apicidin  Chemical Structure
  61. GC46862 Apigenin-d5 An internal standard for the quantification of apigenin Apigenin-d5  Chemical Structure
  62. GC16237 Apocynin Selective NADPH-oxidase inhibitor Apocynin  Chemical Structure
  63. GC14080 Apogossypolone (ApoG2) Apogossypolone (ApoG2)  Chemical Structure
  64. GC42827 Apoptolidin Apoptolidin is an apoptosis inducer originally isolated from Nocardiopsis bacteria. Apoptolidin  Chemical Structure
  65. GC14209 Apoptosis Activator 2 An activator of caspases Apoptosis Activator 2  Chemical Structure
  66. GC14411 Apoptozole inhibitor of heat shock protein 70 (Hsp70) Apoptozole  Chemical Structure
  67. GC65004 Apostatin-1 Apostatin-1 (Apt-1) is a potent TRADD inhibitor. Apostatin-1  Chemical Structure
  68. GC35377 Apratastat An inhibitor of ADAM17 and MMPs Apratastat  Chemical Structure
  69. GC10420 Apremilast (CC-10004) An orally available PDE4 inhibitor Apremilast (CC-10004)  Chemical Structure
  70. GC32692 APTO-253 (LOR-253) APTO-253 (LOR-253) (LOR-253) is a small molecule that inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 (LOR-253)  Chemical Structure
  71. GC14590 AR-42 (OSU-HDAC42)

    HDAC inhibitor,novel and potent

    AR-42 (OSU-HDAC42)  Chemical Structure
  72. GC45385 Ara-G   Ara-G  Chemical Structure
  73. GC46878 Aranciamycin A fungal metabolite with diverse biological activities Aranciamycin  Chemical Structure
  74. GC40116 Aranorosin Aranorosin is a fungal metabolite originally isolated from P. Aranorosin  Chemical Structure
  75. GC65163 Ardisiacrispin B Ardisiacrispin B displays cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death. Ardisiacrispin B  Chemical Structure
  76. GC49314 Arecaidine propargyl ester (hydrobromide) A muscarinic M2 agonist Arecaidine propargyl ester (hydrobromide)  Chemical Structure
  77. GC35388 Aristolactam I Aristololactam I (AL-I), is the main metabolite of aristolochic acid I (AA-I), participates in the processes that lead to renal damage. Aristolactam I  Chemical Structure
  78. GC35395 Arnicolide D Arnicolide D is a sesquiterpene lactone isolated from Centipeda minima. Arnicolide D modulates the cell cycle, activates the caspase signaling pathway and inhibits the PI3K/AKT/mTOR and STAT3 signaling pathways. Arnicolide D inhibits Nasopharyngeal carcinoma (NPC) cell viability in a concentration- and time-dependent manner. Arnicolide D  Chemical Structure
  79. GC19037 ARS-853 ARS-853 is a selective, covalent KRASG12C inhibitor with an IC50 of 2.5 uM. ARS-853  Chemical Structure
  80. GC46882 Artemisinin-d3 An internal standard for the quantification of artemisinin Artemisinin-d3  Chemical Structure
  81. GC10040 Arylquin 1 potent secretagogue of the tumor suppressor protein prostate apoptosis response-4 (Par-4) Arylquin 1  Chemical Structure
  82. GC62615 AS-99 AS-99 is a first-in-class, potent and selective ASH1L histone methyltransferase inhibitor (IC50=0.79μM, Kd=0.89μM) with anti-leukemic activity. AS-99 blocks cell proliferation, induces apoptosis and differentiation, downregulates MLL fusion target genes, and reduces the leukemia burden in vivo. AS-99  Chemical Structure
  83. GC40715 Ascochlorin Ascochlorin is an isoprenoid antibiotic and antiviral that has diverse effects on mammalian cells. Ascochlorin  Chemical Structure
  84. GC13215 Ascomycin(FK 520) A potent macrolide immunosuppressant Ascomycin(FK 520)  Chemical Structure
  85. GC12070 Ascorbic acid An electron donor Ascorbic acid  Chemical Structure
  86. GN10702 Asiatic acid Asiatic acid  Chemical Structure
  87. GN10534 Asiaticoside Asiaticoside  Chemical Structure
  88. GC19041 ASK1-IN-1 ASK1-IN-1 is a potent, orally available and selective ATP-competitive inhibitor of apoptosis signal-regulating kinase 1 (ASK1) with an IC50 of 2.87 nM. ASK1-IN-1  Chemical Structure
  89. GC62426 ASK1-IN-2 ASK1-IN-2 is a potent and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with an IC50 of 32.8 nM. ASK1-IN-2  Chemical Structure
  90. GC42858 Aspergillin PZ Aspergillin PZ is a fungal metabolite originally isolated from A. Aspergillin PZ  Chemical Structure
  91. GN10064 Asperosaponin VI Asperosaponin VI  Chemical Structure
  92. GC60603 Asperosaponin VI A triterpenoid saponin with diverse biological activities Asperosaponin VI  Chemical Structure
  93. GC42860 Aspochalasin D Aspochalasin D is a co-metabolite originally isolated from A. Aspochalasin D  Chemical Structure
  94. GC41640 Asterriquinol D dimethyl ether Asterriquinol D dimethyl ether is a fungal metabolite that has been found in A. Asterriquinol D dimethyl ether  Chemical Structure
  95. GN10415 Astilbin Astilbin  Chemical Structure
  96. GN10561 astragalin astragalin  Chemical Structure
  97. GC18109 Astragaloside A anti-hypertension, positive inotropic action, anti-inflammation, and anti-myocardial injury Astragaloside A  Chemical Structure
  98. GC35415 Astramembrangenin Astramembrangenin  Chemical Structure
  99. GC32803 ASTX660 ASTX660 is an orally bioavailable dual antagonist of cellular inhibitor of apoptosis protein (cIAP) and X-linked inhibitor of apoptosis protein (XIAP). ASTX660  Chemical Structure
  100. GC42863 Asukamycin Asukamycin is polyketide isolated from the S. Asukamycin  Chemical Structure
  101. GC11106 AT-101 AT-101  Chemical Structure

Items 201 to 300 of 2215 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction